- Service Name
United States Drug Testing Laboratories (USDTL)
- Industry
Healthcare, Drug Testing, Forensic Science, Toxicology
- Main Value Proposition
USDTL combines the best science with state-of-the-art technology to deliver the most reliable drug testing services.
- Description
USDTL provides comprehensive drug and alcohol testing services for both newborns and adults. Utilizing advanced technology and scientific methods, they ensure reliable and valid testing results.
- Key Features
Customized drug screening panels; Accredited by The College of American Pathologists; Specialized testing for newborns and children; Wide range of specimen types including hair, nail, and umbilical cord
- Use Cases
USDTL's services are most valuable in scenarios involving prenatal drug exposure, workplace drug testing, and legal cases requiring forensic drug testing.
- Competitive advantages
Accreditation by a recognized authority (The College of American Pathologists); Expertise in both newborn and adult drug testing; Comprehensive resources and support for clients, including educational materials
- Strengths
USDTL's strengths lie in its accreditation, specialized testing capabilities, and commitment to providing reliable results through innovative technology.
- Positioning
USDTL positions itself as a leader in forensic drug testing, emphasizing reliability and scientific integrity.
- Audience
The target users include healthcare providers, legal professionals, and parents concerned about drug exposure in newborns.
- CTA
Get Started Today
- Tags
Drug Testing
Forensic Science
Newborn Testing
Toxicology
- Tagline
experience. innovation. assistance.
- Tone of Voice
Professional, informative, supportive
- Differentiation
USDTL uniquely focuses on both newborn and adult drug testing, offering specialized panels and resources that cater to specific needs, such as SSRIs and fentanyl detection.
- Brand Positioning
USDTL's brand identity is built on trust, expertise, and a commitment to advancing drug testing methodologies.
- Founded
1991-01-01
- Founders
Douglas Lewis